Clinicopathological features of and risk factors for multiple primary melanomas

被引:159
作者
Ferrone, CR
Ben Porat, L
Panageas, KS
Berwick, M
Halpern, AC
Patel, A
Coit, DG
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Dermatol, New York, NY 10021 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 13期
关键词
D O I
10.1001/jama.294.13.1647
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The,incidence of multiple primary melanomas ranges from 1.3% to 8.0% in large retrospective reviews; however, the impact of certain risk factors is not understood. Objectives To determine the incidence of multiple primary melanomas (MPM) from a prospective, single-institution, multidisciplinary database, and to describe the clinical and pathological characteristics and risk factors specific to these patients. Design and Setting Review of a prospectively maintained database at Memorial Sloan-Kettering Cancer Center in New York, NY. Patients A total of 4484 patients diagnosed with a first primary melanoma between January 1, 1996, and December 31, 2002. Main Outcome Measures Incidence of and risk factors for MPM. Results Three hundred eighty-five patients (8.6%) had 2 or more primary melanomas, with an average of 2.3 melanomas per MPM patient. Seventy-eight percent had 2 primary melanomas. For 74% of patients, the initial melanoma was the thickest tumor. Fifty-nine percent presented with their second primary tumor within 1 year. Twenty-one percent of MPM patients had a positive family history of melanoma compared with only 12% of patients with a single primary melanoma (SPM) (P<.001). Thirty-eight percent of MPM patients had dysplastic nevi compared with 18% of SPM patients (P<.001). The estimated cumulative 5-year risk of a second primary tumor for the entire cohort was 11.4%, with almost half of that risk occurring within the first year. For patients with a positive family history or dysplastic nevi, the estimated 5-year risk of MPM was significantly higher at 19.1% and 23.7%, respectively. The most striking increase in incidence for the MPM population was seen for development of a third primary melanoma from the time of second primary melanoma, which was 15.6% at 1 year and 30.9% at 5 years. Conclusions The incidence of MPM is increased in patients with a positive family history and/or dysplastic nevi. These patients should undergo intensive dermatologic screening and should consider genetic testing.
引用
收藏
页码:1647 / 1654
页数:8
相关论文
共 24 条
[1]  
*AM CANC SOC, IN PRESS FACTS FIG 2
[2]   Multiple primary melanoma revisited [J].
Blackwood, MA ;
Holmes, R ;
Synnestvedt, M ;
Young, M ;
George, G ;
Yang, H ;
Elder, DE ;
Schuchter, LM ;
Guerry, D ;
Ganguly, A .
CANCER, 2002, 94 (08) :2248-2255
[3]   Multiple primary melanomas: Implications for screening and follow-up programs for melanoma [J].
Brobeil, A ;
Rapaport, D ;
Wells, K ;
Cruse, CW ;
Glass, F ;
Fenske, N ;
Albertini, J ;
Miliotis, G ;
Messina, J ;
DeConti, R ;
Berman, C ;
Shons, A ;
Cantor, A ;
Reintgen, DS .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (01) :19-23
[4]   MULTIPLE PRIMARY MELANOMA [J].
CASCINELLI, N ;
FONTANA, V ;
CATALDO, I ;
BALZARINI, GP .
TUMORI, 1975, 61 (05) :481-486
[5]  
COOKE KR, 1989, CANCER, V63, P1240, DOI 10.1002/1097-0142(19890315)63:6<1240::AID-CNCR2820630635>3.0.CO
[6]  
2-9
[7]  
CRUTCHER WA, 1984, LANCET, V1, P729
[8]   Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma [J].
DiFronzo, LA ;
Wanek, LA ;
Elashoff, R ;
Morton, DL .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (07) :705-711
[9]   MULTIPLE PRIMARY MELANOMAS - AN ANALYSIS OF CANCER REGISTRY DATA FROM VICTORIA AND NEW-SOUTH-WALES [J].
GILES, G ;
STAPLES, M ;
MCCREDIE, M ;
COATES, M .
MELANOMA RESEARCH, 1995, 5 (06) :433-438
[10]   A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors [J].
Goggins, WB ;
Tsao, H .
CANCER, 2003, 97 (03) :639-643